These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 30015176)

  • 1. Synthesis, thymidine phosphorylase inhibitory and computational study of novel 1,3,4-oxadiazole-2-thione derivatives as potential anticancer agents.
    Bajaj S; Roy PP; Singh J
    Comput Biol Chem; 2018 Oct; 76():151-160. PubMed ID: 30015176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, thymidine phosphorylase inhibition and molecular modeling studies of 1,3,4-oxadiazole-2-thione derivatives.
    Shahzad SA; Yar M; Bajda M; Shahzadi L; Khan ZA; Naqvi SA; Mutahir S; Mahmood N; Khan KM
    Bioorg Chem; 2015 Jun; 60():37-41. PubMed ID: 25920005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, modelling studies and biological evaluation of 1,3,4-oxadiazole derivatives as potent anticancer agents targeting thymidine phosphorylase enzyme.
    Bajaj S; Kumar MS; Tinwala H; Yc M
    Bioorg Chem; 2021 Jun; 111():104873. PubMed ID: 33845381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of novel oxadiazole derivatives: a new class of thymidine phosphorylase inhibitors as potential anti-tumor agents.
    Shahzad SA; Yar M; Bajda M; Jadoon B; Khan ZA; Naqvi SA; Shaikh AJ; Hayat K; Mahmmod A; Mahmood N; Filipek S
    Bioorg Med Chem; 2014 Feb; 22(3):1008-15. PubMed ID: 24411198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, molecular docking study and in vitro thymidine phosphorylase inhibitory potential of oxadiazole derivatives.
    Ullah H; Rahim F; Taha M; Uddin I; Wadood A; Shah SAA; Farooq RK; Nawaz M; Wahab Z; Khan KM
    Bioorg Chem; 2018 Aug; 78():58-67. PubMed ID: 29533215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, SAR elucidations and molecular docking study of newly designed isatin based oxadiazole analogs as potent inhibitors of thymidine phosphorylase.
    Javid MT; Rahim F; Taha M; Nawaz M; Wadood A; Ali M; Mosaddik A; Shah SAA; Farooq RK
    Bioorg Chem; 2018 Sep; 79():323-333. PubMed ID: 29803079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a series of 1,3,4-oxadiazole-2(3H)-thione derivatives containing piperazine skeleton as potential FAK inhibitors.
    Sun J; Ren SZ; Lu XY; Li JJ; Shen FQ; Xu C; Zhu HL
    Bioorg Med Chem; 2017 May; 25(9):2593-2600. PubMed ID: 28363444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,3,4-oxadiazole-2-thione Derivatives; Novel Approach for Anticancer and Tubulin Polymerization Inhibitory Activities.
    Abdel-Aziz M; Metwally KA; Gamal-Eldeen AM; Aly OM
    Anticancer Agents Med Chem; 2015; 16(2):269-77. PubMed ID: 26343141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives: promising anticancer agents.
    Aboraia AS; Abdel-Rahman HM; Mahfouz NM; El-Gendy MA
    Bioorg Med Chem; 2006 Feb; 14(4):1236-46. PubMed ID: 16242340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design of bis-indolylmethane-oxadiazole hybrids as inhibitors of thymidine phosphorylase.
    Taha M; Rashid U; Imran S; Ali M
    Bioorg Med Chem; 2018 Jul; 26(12):3654-3663. PubMed ID: 29853339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.
    Sun J; Zhu H; Yang ZM; Zhu HL
    Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological evaluation, and molecular docking studies of novel 1,3,4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity.
    Zhang S; Luo Y; He LQ; Liu ZJ; Jiang AQ; Yang YH; Zhu HL
    Bioorg Med Chem; 2013 Jul; 21(13):3723-9. PubMed ID: 23673215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of 1,2,4-triazoles as new thymidine phosphorylase inhibitors: Future anti-tumor drugs.
    Shahzad SA; Yar M; Khan ZA; Shahzadi L; Naqvi SAR; Mahmood A; Ullah S; Shaikh AJ; Sherazi TA; Bale AT; Kukułowicz J; Bajda M
    Bioorg Chem; 2019 Apr; 85():209-220. PubMed ID: 30634096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico binding analysis and SAR elucidations of newly designed benzopyrazine analogs as potent inhibitors of thymidine phosphorylase.
    Taha M; Ismail NH; Imran S; Rahim F; Wadood A; Al Muqarrabun LM; Khan KM; Ghufran M; Ali M
    Bioorg Chem; 2016 Oct; 68():80-9. PubMed ID: 27474803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, evaluation of thymidine phosphorylase and angiogenic inhibitory potential of ciprofloxacin analogues: Repositioning of ciprofloxacin from antibiotic to future anticancer drugs.
    Shahzad SA; Sarfraz A; Yar M; Khan ZA; Naqvi SAR; Naz S; Khan NA; Farooq U; Batool R; Ali M
    Bioorg Chem; 2020 Jul; 100():103876. PubMed ID: 32388426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, anti-thymidine phosphorylase activity and molecular docking of 5-thioxo-[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-ones.
    Bera H; Lee MH; Sun L; Dolzhenko AV; Chui WK
    Bioorg Chem; 2013 Oct; 50():34-40. PubMed ID: 23968897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of 1,3,4-oxadiazole thione based novel anticancer agents: Design, synthesis and in-vitro studies.
    Yadav N; Kumar P; Chhikara A; Chopra M
    Biomed Pharmacother; 2017 Nov; 95():721-730. PubMed ID: 28888209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound- and Molecular Sieves-Assisted Synthesis, Molecular Docking and Antifungal Evaluation of 5-(4-(Benzyloxy)-substituted phenyl)-3-((phenylamino)methyl)-1,3,4-oxadiazole-2(3H)-thiones.
    Nimbalkar UD; Tupe SG; Seijas Vazquez JA; Khan FA; Sangshetti JN; Nikalje AP
    Molecules; 2016 May; 21(5):. PubMed ID: 27171073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, in-vitro thymidine phosphorylase inhibition, in-vivo antiangiogenic and in-silico studies of C-6 substituted dihydropyrimidines.
    Iftikhar F; Yaqoob F; Tabassum N; Jan MS; Sadiq A; Tahir S; Batool T; Niaz B; Ansari FL; Choudhary MI; Rashid U
    Bioorg Chem; 2018 Oct; 80():99-111. PubMed ID: 29894893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents.
    Zhang XM; Qiu M; Sun J; Zhang YB; Yang YS; Wang XL; Tang JF; Zhu HL
    Bioorg Med Chem; 2011 Nov; 19(21):6518-24. PubMed ID: 21962523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.